This trial will compare the rate of infection and other complications after in-office transperineal MRI targeted prostate biopsy to the standard transrectal MRI targeted prostate biopsy.
1 Primary · 4 Secondary · Reporting Duration: 7 days post-biopsy
Active Control
1302 Total Participants · 2 Treatment Groups
Primary Treatment: Transperineal · No Placebo Group · N/A
Age 18+ · Male Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: